BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 22105598)

  • 1. Direct interaction of PU.1 with oncogenic transcription factors reduces its serine phosphorylation and promoter binding.
    Seshire A; Rößiger T; Frech M; Beez S; Hagemeyer H; Puccetti E
    Leukemia; 2012 Jun; 26(6):1338-47. PubMed ID: 22105598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of the hematopoietic cell kinase (HCK) by PML/RARα and PU.1 in acute promyelocytic leukemia.
    Zou D; Yang X; Tan Y; Wang P; Zhu X; Yang W; Jia X; Zhang J; Wang K
    Leuk Res; 2012 Feb; 36(2):219-23. PubMed ID: 21993313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The integrity of the charged pocket in the BTB/POZ domain is essential for the phenotype induced by the leukemia-associated t(11;17) fusion protein PLZF/RARalpha.
    Puccetti E; Zheng X; Brambilla D; Seshire A; Beissert T; Boehrer S; Nürnberger H; Hoelzer D; Ottmann OG; Nervi C; Ruthardt M
    Cancer Res; 2005 Jul; 65(14):6080-8. PubMed ID: 16024608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-fms expression correlates with monocytic differentiation in PML-RAR alpha+ acute promyelocytic leukemia.
    Riccioni R; Saulle E; Militi S; Sposi NM; Gualtiero M; Mauro N; Mancini M; Diverio D; Lo Coco F; Peschle C; Testa U
    Leukemia; 2003 Jan; 17(1):98-113. PubMed ID: 12529666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PML/RARalpha targets promoter regions containing PU.1 consensus and RARE half sites in acute promyelocytic leukemia.
    Wang K; Wang P; Shi J; Zhu X; He M; Jia X; Yang X; Qiu F; Jin W; Qian M; Fang H; Mi J; Yang X; Xiao H; Minden M; Du Y; Chen Z; Zhang J
    Cancer Cell; 2010 Feb; 17(2):186-97. PubMed ID: 20159610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The methyl-CpG binding protein MBD1 is required for PML-RARalpha function.
    Villa R; Morey L; Raker VA; Buschbeck M; Gutierrez A; De Santis F; Corsaro M; Varas F; Bossi D; Minucci S; Pelicci PG; Di Croce L
    Proc Natl Acad Sci U S A; 2006 Jan; 103(5):1400-5. PubMed ID: 16432238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C/EBPα and PU.1 are involved in distinct differentiation responses of acute promyelocytic leukemia HL-60 and NB4 cells via chromatin remodeling.
    Savickiene J; Treigyte G; Vistartaite G; Tunaitis V; Magnusson KE; Navakauskiene R
    Differentiation; 2011 Jan; 81(1):57-67. PubMed ID: 20864248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new molecular network comprising PU.1, interferon regulatory factor proteins and miR-342 stimulates ATRA-mediated granulocytic differentiation of acute promyelocytic leukemia cells.
    De Marchis ML; Ballarino M; Salvatori B; Puzzolo MC; Bozzoni I; Fatica A
    Leukemia; 2009 May; 23(5):856-62. PubMed ID: 19151778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The self-association coiled-coil domain of PML is sufficient for the oncogenic conversion of the retinoic acid receptor (RAR) alpha.
    Occhionorelli M; Santoro F; Pallavicini I; Gruszka A; Moretti S; Bossi D; Viale A; Shing D; Ronzoni S; Muradore I; Soncini M; Pruneri G; Rafaniello P; Viale G; Pelicci PG; Minucci S
    Leukemia; 2011 May; 25(5):814-20. PubMed ID: 21331069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the acute promyelocytic leukemia-associated fusion proteins PML/RARα and PLZF/RARα with interfering peptides.
    Beez S; Demmer P; Puccetti E
    PLoS One; 2012; 7(11):e48636. PubMed ID: 23152790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coordinated regulation of the immunoproteasome subunits by PML/RARα and PU.1 in acute promyelocytic leukemia.
    Yang XW; Wang P; Liu JQ; Zhang H; Xi WD; Jia XH; Wang KK
    Oncogene; 2014 May; 33(21):2700-8. PubMed ID: 23770850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PML/RARalpha, a fusion protein in acute promyelocytic leukemia, prevents growth factor withdrawal-induced apoptosis in TF-1 cells.
    Fu S; Consoli U; Hanania EG; Zu Z; Claxton DF; Andreeff M; Deisseroth AB
    Clin Cancer Res; 1995 Jun; 1(6):583-90. PubMed ID: 9816019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced PU.1 expression causes myeloid progenitor expansion and increased leukemia penetrance in mice expressing PML-RARalpha.
    Walter MJ; Park JS; Ries RE; Lau SK; McLellan M; Jaeger S; Wilson RK; Mardis ER; Ley TJ
    Proc Natl Acad Sci U S A; 2005 Aug; 102(35):12513-8. PubMed ID: 16113082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic analysis of acute promyelocytic leukemia: PML-RARalpha leads to decreased phosphorylation of OP18 at serine 63.
    Zada AA; Geletu MH; Pulikkan JA; Müller-Tidow C; Reddy VA; Christopeit M; Hiddemann WD; Behre HM; Tenen DG; Behre G
    Proteomics; 2006 Nov; 6(21):5705-19. PubMed ID: 17001604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The significance of low PU.1 expression in patients with acute promyelocytic leukemia.
    Zhu X; Zhang H; Qian M; Zhao X; Yang W; Wang P; Zhang J; Wang K
    J Hematol Oncol; 2012 May; 5():22. PubMed ID: 22569057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pro-proliferative function of the long isoform of PML-RARalpha involved in acute promyelocytic leukemia.
    Tussié-Luna MI; Rozo L; Roy AL
    Oncogene; 2006 Jun; 25(24):3375-86. PubMed ID: 16434964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RARα-PLZF oncogene inhibits C/EBPα function in myeloid cells.
    Girard N; Tremblay M; Humbert M; Grondin B; Haman A; Labrecque J; Chen B; Chen Z; Chen SJ; Hoang T
    Proc Natl Acad Sci U S A; 2013 Aug; 110(33):13522-7. PubMed ID: 23898169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PML-RAR alpha induces the downmodulation of HHEX: a key event responsible for the induction of an angiogenetic response.
    Saulle E; Petronelli A; Pelosi E; Coppotelli E; Pasquini L; Ilari R; Lo-Coco F; Testa U
    J Hematol Oncol; 2016 Apr; 9():33. PubMed ID: 27052408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structurally differentiated cis-elements that interact with PU.1 are functionally distinguishable in acute promyelocytic leukemia.
    Qian M; Jin W; Zhu X; Jia X; Yang X; Du Y; Wang K; Zhang J
    J Hematol Oncol; 2013 Apr; 6():25. PubMed ID: 23547873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PU.1 can regulate the ZNF300 promoter in APL-derived promyelocytes HL-60.
    Xu JH; Wang T; Wang XG; Wu XP; Zhao ZZ; Zhu CG; Qiu HL; Xue L; Shao HJ; Guo MX; Li WX
    Leuk Res; 2010 Dec; 34(12):1636-46. PubMed ID: 20471086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.